Incremental prognostic value of echocardiography of left ventricular remodeling and diastolic function in STICH trial

Kyung Hee Kim, Lilin She, Kerry L. Lee, Rafal Dabrowski, Paul A. Grayburn, Miroslaw Rajda, David L. Prior, Patrice Desvigne-Nickens, William A. Zoghbi, Michele Senni, Guglielmo Stefanelli, Cesare Beghi, Thao Huynh, Eric J. Velazquez, Jae K. Oh, Grace Lin

Research output: Contribution to journalArticle

Abstract

Aims: We sought to determine which echocardiographic markers of left ventricular (LV) remodeling and diastolic dysfunction can contribute as incremental and independent prognostic information in addition to current clinical risk markers of ischemic LV systolic dysfunction in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Methods and results: The cohort consisted of 1511 of 2136 patients in STICH for whom baseline transmitral Doppler (E/A ratio) could be measured by an echocardiographic core laboratory blinded to treatment and outcomes, and prognostic value of echocardiographic variables was determined by a Cox regression model. E/A ratio was the most significant predictor of mortality amongst diastolic variables with lowest mortality for E/A closest 0.8, although mortality was consistently low for E/A 0.6 to 1.0. Mortality increased for E/A < 0.6 and > 1.0 up to approximately 2.3, beyond which there was no further increase in risk. Larger LV end-systolic volume index (LVESVI) and E/A < 0.6 and > 1.0 had incremental negative effects on mortality when added to a clinical multivariable model, where creatinine, LVESVI, age, and E/A ratio accounted for 74% of the prognostic information for predicting risk. LVESVI and E/A ratio were stronger predictors of prognosis than New York Heart Association functional class, anemia, diabetes, history of atrial fibrillation, and stroke. Conclusions: Echocardiographic markers of advanced LV remodeling and diastolic dysfunction added incremental prognostic value to current clinical risk markers. LVESVI and E/A ratio outperformed other markers and should be considered as standard in assessing risks in ischemic heart failure. E/A closest to 0.8 was the most optimal filling pattern.

Original languageEnglish (US)
Article number17
JournalCardiovascular ultrasound
Volume18
Issue number1
DOIs
StatePublished - May 28 2020

Keywords

  • Diastolic dysfunction.
  • Heart failure
  • Ischemic cardiomyopathy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Incremental prognostic value of echocardiography of left ventricular remodeling and diastolic function in STICH trial'. Together they form a unique fingerprint.

  • Cite this

    Kim, K. H., She, L., Lee, K. L., Dabrowski, R., Grayburn, P. A., Rajda, M., Prior, D. L., Desvigne-Nickens, P., Zoghbi, W. A., Senni, M., Stefanelli, G., Beghi, C., Huynh, T., Velazquez, E. J., Oh, J. K., & Lin, G. (2020). Incremental prognostic value of echocardiography of left ventricular remodeling and diastolic function in STICH trial. Cardiovascular ultrasound, 18(1), [17]. https://doi.org/10.1186/s12947-020-00195-1